Shows Main Header
 

Clinical and Translational Toxicology Specialty Section

The Clinical and Translational Toxicology Specialty Section (CTTSS) is a subgroup of the Society of Toxicology, the membership of which has expertise in all aspects of clinical and translational toxicology. Members interested in the impact of pharmaceuticals, chemicals, plants, fungi, toxic terrestrial and marine animals on human health, can share their knowledge and propose new approaches for the treatment of these exposures, based on an understanding of their mechanisms of toxicity. The CTTSS will stimulate discussion on the optimal regimens for treatment based on a detailed understanding of the toxicokinetics and toxicodynamics of the agent involved and the pharmacology and adverse effects of the proposed treatment. The CTTSS is committed to improving the management of human poisoning by using a translational approach that links molecular mechanisms to rational therapy.

The Section will hold regular meetings at the SOT Annual Meetings to discuss topics of interest to the membership.

The elected officials will consist of the President, Vice President, Vice President-Elect, Secretary/Treasurer and two Councilors. For a current listing of the CTTSS Officers, view the Officers Page.

Key Issues and Goals

  1. To serve as the focal point for the interaction of members of the Society of Toxicology interested in clinical and translational toxicology and to stimulate new interest among Society members in all aspects of human toxicology.
  2. To increase awareness among Society members of the impact of acute and chronic poisoning as seen in clinical practice; to highlight shortfalls in the available diagnostic and treatment methods, especially therapeutic interventions; to identify uncertainty in regards to the pathogenic processes in some intoxications and to stimulate research that will enhance the diagnosis and treatment of patients with acute or chronic poisoning.
  3. To act as a resource for the Society in the area of human toxicology.
  4. To develop, propose, and sponsor state-of-the-art symposia, workshops and continuing education courses at the Annual Meeting of the Society of Toxicology in order to emphasize the latest developments and issues in clinical and translational toxicology.